Unknown

Dataset Information

0

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.

ABSTRACT:

SUBMITTER: Bezerra ED 

PROVIDER: S-EPMC7952717 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival.
| S-EPMC7686903 | biostudies-literature
Unknown Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
| S-EPMC6886439 | biostudies-literature
Genomics Epigenome of ASXL1-mutant and ASXL1-wildtype chronic myelomonocytic leukemia
2022-02-21 | GSE159886 | GEO
Transcriptomics Transcriptome of ASXL1-mutant and ASXL1-wildtype chronic myelomonocytic leukemia
2022-02-21 | GSE159543 | GEO
Unknown SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
| S-EPMC3580040 | biostudies-literature
Genomics Epigenome of ASXL1-mutant and ASXL1-wildtype chronic myelomonocytic leukemia
| PRJNA670720 | ENA
Genomics Transcriptome of ASXL1-mutant and ASXL1-wildtype chronic myelomonocytic leukemia
| PRJNA670006 | ENA
Unknown Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia.
| S-EPMC4742630 | biostudies-other
Unknown Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML).
| S-EPMC8036734 | biostudies-literature
Unknown Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
| S-EPMC6056400 | biostudies-literature